NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Abstract The molecular basis for accelerated cognitive decline seen in Alzheimer’s Disease (AD) cases presenting with cortical alpha-Synuclein (SNCA/⍺-Syn) co-pathology is not well understood. We show that such AD co-pathology brains are characterized by an increased polygenic risk score for Parkinson’s Disease (PD), which is related to an enrichment in the MAPT H1 haplotype as well as risk factors known to increase SNCA transcription. AD + ASYN brains express higher levels of ⍺-Syn and neuronal microtubule-associated protein tau (MAPT), and increasing SNCA expression is sufficient to drive transcription, translation and phosphorylation of tau. In addition, tau is significantly elevated in subjects with a positive cerebrospinal fluid ⍺-Syn seeding aggregation assay. Our results reveal a hitherto unknown link between the pathogenesis of AD and PD whereby tau and ⍺-Syn synergistically drive dementia-related pathology.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.